查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1519525

2024-2032 年按产品、适应症、配销通路和地区分類的马保健市场

Equine Healthcare Market by Product, Indication, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球马保健市场规模达15亿美元。马匹数量的快速增加、马主对马匹健康和适当营养的认识不断提高以及先进成像技术的利用是推动市场发展的一些关键因素。

马医疗保健是兽医学的一个分支，专注于马疾病的诊断、治疗和预防。它涉及各种产品的利用，如疫苗、驱虫剂、局部治疗、关节补充剂、益生元、灭蝇喷雾剂、蹄部调理剂、防腐剂和功能添加剂。马医疗保健包括预防护理、疾病管理、跛行治疗、生殖护理、口腔卫生、復健和解决行为问题。它有助于改善整体健康，预防未来的併发症，允许早期疾病检测，促进成功繁殖，促进更长的寿命，并降低严重疾病的风险，如跛行、牙齿问题、感染、肥胖、疱疹和狂犬病。

马保健市场趋势：

由于马匹广泛用于赛马、农耕和作为伴侣，马匹数量迅速增加，这是推动市场成长的主要因素之一。马保健服务和产品，如预防保健、生殖服务、復健中心、疫苗和保健品，被广泛使用，以确保最佳性能、预防併发症、防止受伤并降低疾病风险。除此之外，马主对马健康和适当营养重要性的认识不断提高，也是另一个促进生长的因素。此外，政府实施的各种支持动物福利、促进负责任的所有权和提供高品质医疗设施的措施正在对市场成长产生积极影响。此外，利用先进的成像技术，如数位射线照相、超音波和内视镜检查，提供马身体的详细横断面影像，从而可以诊断肌肉骨骼损伤、跛行和内科疾病，正在为市场做出贡献。除此之外，最近开发的马匹穿戴式健康监测设备可以持续监测生命征象、活动量和行为，以便及早发现任何健康问题，这为市场成长提供了动力。此外，赛马、障碍赛、盛装舞步和耐力赛等马术运动的不断增加正在推动市场的成长。其他因素，包括消费者支出能力的提高、宠物人性化的新兴趋势、广泛的研发（R＆D）活动以及电子商务行业的快速扩张，预计将推动市场成长。

本报告回答的关键问题：

  • 迄今为止，全球马保健市场表现如何，未来几年将如何表现？
  • 全球马保健市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球马保健市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的马匹保健市场？
  • 基于产品的市场区隔是什么？
  • 马保健市场上最具吸引力的产品是什么？
  • 根据指示，市场的细分是什么？
  • 马保健市场上最具吸引力的适应症是什么？
  • 基于配销通路的市场区隔是什么？
  • 马保健品市场中哪个配销通路最具吸引力？
  • 全球马匹保健市场的竞争结构如何？
  • 谁是全球马保健市场的主要参与者/公司？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球马保健市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 药品
    • 市场走向
    • 关键环节
      • 抗发炎药
      • 杀寄生虫药
      • 其他的
    • 市场预测
  • 疫苗
    • 市场走向
    • 关键环节
      • 减毒活疫苗
      • 重组疫苗
      • 其他的
    • 市场预测
  • 药用饲料添加剂
    • 市场走向
    • 市场预测
  • 诊断
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依迹象

  • 肌肉骨骼疾病
    • 市场走向
    • 市场预测
  • 寄生虫控制
    • 市场走向
    • 市场预测
  • 马疱疹病毒
    • 市场走向
    • 市场预测
  • 马脑脊髓炎
    • 市场走向
    • 市场预测
  • 马流感
    • 市场走向
    • 市场预测
  • 西尼罗病毒
    • 市场走向
    • 市场预测
  • 破伤风
    • 市场走向
    • 市场预测
  • 狂犬病
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按配销通路

  • 兽医医院和诊所
    • 市场走向
    • 市场预测
  • 零售药局和药局
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：驱动因素、限制与机会

  • 概述
  • 司机
  • 限制
  • 机会

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Boehringer Ingelheim International GmbH
    • Ceva
    • Dechra Pharmaceuticals PLC
    • Elanco Animal Health Incorporated
    • Esaote SpA
    • Hallmarq Veterinary Imaging
    • IDEXX Laboratories Inc.
    • Merck & Co. Inc.
    • Vetoquinol SA
    • Zoetis Inc
Product Code: SR112024A7779

The global equine healthcare market size reached US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5.6% during 2024-2032. The rapid increase in the equine population, rising awareness among owners regarding equine health and proper nutrition, and the utilization of advanced imaging techniques represent some of the key factors driving the market.

Equine healthcare is a branch of veterinary medicine that focuses on the diagnosis, treatment, and prevention of diseases in horses. It involves the utilization of various products, such as vaccines, dewormers, topical treatments, joint supplements, prebiotics, fly sprays, hoof conditioners, antiseptics, and performance additives. Equine healthcare includes preventive care, illness management, lameness treatment, reproductive care, oral hygiene, rehabilitation, and addressing behavioral issues. It assists in improving overall health, preventing future complications, allowing early disease detection, facilitating successful breeding, promoting a longer lifespan, and reducing the risk of serious diseases, such as lameness, dental problems, infections, obesity, herpes, and rabies.

Equine Healthcare Market Trends:

The rapid increase in the equine population due to the widespread utilization of horses in racing, farming, and as companions is one of the primary factors propelling the market growth. Equine healthcare services and products, such as preventive care, reproductive services, rehabilitation centers, vaccines, and health supplements, are widely used to ensure optimum performance, prevent complications, protect from injuries, and reduce the risk of illnesses. In addition to this, rising awareness among the owners regarding the importance of equine health and proper nutrition is acting as another growth-inducing factor. Furthermore, the implementation of various government initiatives to support animal welfare, promote responsible ownership, and provide access to high-quality healthcare facilities is positively influencing the market growth. Additionally, the utilization of advanced imaging techniques, such as digital radiography, ultrasound, and endoscopy, to provide detailed cross-sectional images of the horse's body, thus allowing the diagnosis of musculoskeletal injuries, lameness, and internal diseases, is contributing to the market growth. Besides this, the recent development of wearable health monitoring devices for horses, which allows continuous monitoring of vital signs, activity levels, and behavior to facilitate early detection of any health issues, is providing an impetus to the market growth. Moreover, the growing number of equine sports, such as racing, jumping, dressage, and endurance riding, is propelling the market growth. Other factors, including rising expenditure capacities of consumers, emerging trends of pet humanization, extensive research and development (R&D) activities, and rapid expansion of the e-commerce industry, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global equine healthcare market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, indication, and distribution channel.

Product Insights:

Drugs

Anti-Inflammatory Drugs

Parasiticide Drugs

Others

Vaccines

Live Attenuated Vaccine

Recombinant Vaccine

Others

Medicated Feed Additives

Diagnostics

Others

The report has provided a detailed breakup and analysis of the equine healthcare market based on the product. This includes drugs (anti-inflammatory drugs, parasiticide drugs, and others), vaccines (live attenuated vaccine, recombinant vaccine, and others), medicated feed additives, diagnostics, and others. According to the report, drugs represented the largest segment.

Indication Insights:

Musculoskeletal Disorders

Parasite Control

Equine Herpes Virus

Equine Encephalomyelitis

Equine Influenza

West Nile Virus

Tetanus

Rabies

Others

A detailed breakup and analysis of the equine healthcare market based on the indication has also been provided in the report. This includes musculoskeletal disorders, parasite control, equine herpes virus, equine encephalomyelitis, equine influenza, West Nile virus, tetanus, rabies, and others. According to the report, parasite control accounted for the largest market share.

Distribution Channel Insights:

Veterinary Hospitals and Clinics

Retail Pharmacies and Drug Stores

A detailed breakup and analysis of the equine healthcare market based on the distribution channel has also been provided in the report. This includes veterinary hospitals and clinics and retail pharmacies and drug stores. According to the report, veterinary hospitals and clinics accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for equine healthcare. Some of the factors driving the North America equine healthcare market included the rising equine population, supportive government policies, and significant technological advancements.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global equine healthcare market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Boehringer Ingelheim International GmbH, Ceva, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Esaote SpA, Hallmarq Veterinary Imaging, IDEXX Laboratories Inc., Merck & Co. Inc., Vetoquinol S.A., Zoetis Inc, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global equine healthcare market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global equine healthcare market?
  • What is the impact of each driver, restraint, and opportunity on the global equine healthcare market?
  • What are the key regional markets?
  • Which countries represent the most attractive equine healthcare market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the equine healthcare market?
  • What is the breakup of the market based on the indication?
  • Which is the most attractive indication in the equine healthcare market?
  • What is the breakup of the market based on distribution channel?
  • Which is the most attractive distribution channel in the equine healthcare market?
  • What is the competitive structure of the global equine healthcare market?
  • Who are the key players/companies in the global equine healthcare market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Equine Healthcare Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Drugs
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Anti-Inflammatory Drugs
      • 6.1.2.2 Parasiticide Drugs
      • 6.1.2.3 Others
    • 6.1.3 Market Forecast
  • 6.2 Vaccines
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Live Attenuated Vaccine
      • 6.2.2.2 Recombinant Vaccine
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast
  • 6.3 Medicated Feed Additives
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Diagnostics
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Musculoskeletal Disorders
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Parasite Control
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Equine Herpes Virus
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Equine Encephalomyelitis
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Equine Influenza
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 West Nile Virus
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Tetanus
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Rabies
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast
  • 7.9 Others
    • 7.9.1 Market Trends
    • 7.9.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Veterinary Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies and Drug Stores
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Boehringer Ingelheim International GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2 Ceva
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Dechra Pharmaceuticals PLC
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Elanco Animal Health Incorporated
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Esaote SpA
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 Hallmarq Veterinary Imaging
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7 IDEXX Laboratories Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Merck & Co. Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Vetoquinol S.A.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Zoetis Inc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Equine Healthcare Market: Major Drivers and Challenges
  • Figure 2: Global: Equine Healthcare Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Equine Healthcare Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Equine Healthcare Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Equine Healthcare Market: Breakup by Indication (in %), 2023
  • Figure 6: Global: Equine Healthcare Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Equine Healthcare Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Equine Healthcare (Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Equine Healthcare (Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Equine Healthcare (Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Equine Healthcare (Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Equine Healthcare (Medicated Feed Additives) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Equine Healthcare (Medicated Feed Additives) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Equine Healthcare (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Equine Healthcare (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Equine Healthcare (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Equine Healthcare (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Equine Healthcare (Musculoskeletal Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Equine Healthcare (Musculoskeletal Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Equine Healthcare (Parasite Control) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Equine Healthcare (Parasite Control) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Equine Healthcare (Equine Herpes Virus) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Equine Healthcare (Equine Herpes Virus) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Equine Healthcare (Equine Encephalomyelitis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Equine Healthcare (Equine Encephalomyelitis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Equine Healthcare (Equine Influenza) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Equine Healthcare (Equine Influenza) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Equine Healthcare (West Nile Virus) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Equine Healthcare (West Nile Virus) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Equine Healthcare (Tetanus) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Equine Healthcare (Tetanus) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Equine Healthcare (Rabies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Equine Healthcare (Rabies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Equine Healthcare (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Equine Healthcare (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Equine Healthcare (Veterinary Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Equine Healthcare (Veterinary Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Equine Healthcare (Retail Pharmacies and Drug Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Equine Healthcare (Retail Pharmacies and Drug Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: North America: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: North America: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: United States: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: United States: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Canada: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Canada: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Asia-Pacific: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Asia-Pacific: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: China: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: China: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Japan: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Japan: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: India: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: India: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: South Korea: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: South Korea: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Australia: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Australia: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Indonesia: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Indonesia: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Others: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Others: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Europe: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Europe: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Germany: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Germany: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: France: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: France: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: United Kingdom: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: United Kingdom: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Italy: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Italy: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Spain: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Spain: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Russia: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Russia: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Latin America: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Latin America: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Brazil: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Brazil: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Mexico: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Mexico: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Others: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Others: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Middle East and Africa: Equine Healthcare Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Middle East and Africa: Equine Healthcare Market: Breakup by Country (in %), 2023
  • Figure 88: Middle East and Africa: Equine Healthcare Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Global: Equine Healthcare Industry: Drivers, Restraints, and Opportunities
  • Figure 90: Global: Equine Healthcare Industry: Value Chain Analysis
  • Figure 91: Global: Equine Healthcare Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Equine Healthcare Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Equine Healthcare Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Equine Healthcare Market Forecast: Breakup by Indication (in Million US$), 2024-2032
  • Table 4: Global: Equine Healthcare Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Equine Healthcare Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Equine Healthcare Market: Competitive Structure
  • Table 7: Global: Equine Healthcare Market: Key Players